Asset Details
Do you wish to reserve the book?
Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study
Do you wish to request the book?
Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study
2025
Overview
Objective
To investigate the impact of COVID-19 infection on maternal and neonatal outcomes and immunity in pregnant women in China.
Methods
283 pregnant women with COVID-19 were included in the prospective observational cohort study and divided into five groups based on infection stage. Antibody levels were measured in plasma, umbilical cord blood, and breast milk, and combined with clinical data and 6-month follow-up results. We measured SARS-CoV-2 antibody levels using a chemiluminescence immunoassay and analyzed the data with the Kruskal-Wallis test, χ2 test, or Fisher’s exact test.
Results
No significant differences were found in age, BMI, weight change during pregnancy, or the incidence of gestational hypertension, gestational diabetes, gestational hypothyroidism, intrahepatic cholestasis, transaminitis, preterm birth, small for gestational age, neonatal NICU transfers, developmental delays, and hearing damage among the five groups. The incidence of COVID-19 in infants from mothers infected at different stages of pregnancy was significantly lower than in the uninfected group (
P
< 0.05). Maternal and umbilical cord blood showed significantly higher IgG levels in the infected group compared to the uninfected group at different stages of pregnancy (
P
< 0.05). The median transplacental antibody transfer ratio across all infection groups was 1.15 (0.98–1.30), with no significant differences between them. The reinfection group had significantly higher IgA levels during pregnancy compared to other groups (
P
< 0.05).
Conclusion
No adverse outcomes were observed in mothers or infants at any stage of maternal SARS-CoV-2 infection. Antibodies in umbilical cord blood and breast milk may offer passive immunity to newborns for 1–3 months. Reinfection during pregnancy may extend this immunity without raising the risk of adverse outcomes.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
/ Antibodies, Viral - analysis
/ Antibody
/ Babies
/ COVID-19
/ Dyspnea
/ Effects of maternal infection and inflammation on maternal-fetal outcomes
/ Female
/ Humans
/ Infant
/ Infectious Disease Transmission, Vertical
/ Medicine
/ Pregnancy Complications, Infectious - epidemiology
/ Pregnancy Complications, Infectious - immunology
/ Pregnancy Complications, Infectious - virology
/ Pregnancy Outcome - epidemiology
